Related Experiment Video
Updated: Aug 10, 2025
11:12
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
8.1K
Systemically Identifying Triple-Negative Breast Cancer Subtype-Specific Prognosis Signatures, Based on Single-Cell
Kaiyuan Xing1, Bo Zhang2, Zixuan Wang1
1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.
Cells
|February 11, 2023
Summary
This study introduces a novel single-cell RNA sequencing bioinformatics approach to identify triple-negative breast cancer (TNBC) subtype-specific prognostic signatures (TSPSigs). These identified TSPSigs show promise as new biomarkers for predicting patient outcomes and guiding personalized treatment strategies.
Area of Science:
- Oncology
- Genomics
- Bioinformatics
Background:
- Triple-negative breast cancer (TNBC) is a heterogeneous disease with limited targeted therapies.
- Traditional bulk RNA sequencing methods face limitations in identifying subtype-specific biomarkers due to sample heterogeneity.
Purpose of the Study:
- To develop a single-cell RNA sequencing (scRNA-seq) based bioinformatics approach to identify TNBC subtype-specific prognostic signatures (TSPSigs).
- To validate the prognostic power and clinical relevance of identified TSPSigs in TNBC.
Main Methods:
- Utilized a scRNA-seq-based bioinformatics approach to identify TSPSigs.
- Performed enrichment analysis to determine the biological relevance of TSPSigs.
- Validated TSPSigs in four independent datasets using multivariate analysis.
- Analyzed the association between TSPSigs expression and drug sensitivity in TNBC cell lines.
Main Results:
- Identified TSPSigs that are largely disease-related and involved in cancer development.
- Confirmed the significant prognostic power of TSPSigs across multiple independent validation datasets.
- Demonstrated that TSPSigs in BL1 and LAR subtypes are independent prognostic factors.
- Found significant associations between TSPSigs expression and drug sensitivities in TNBC cell lines.
Conclusions:
- TSPSigs identified through scRNA-seq analysis represent novel candidate prognostic markers for TNBC.
- These TSPSigs hold potential for application in the future individualized treatment of TNBC patients.
